Use of aminophylline in the treatment of heart disease
Banerjea, J.C.
Indian Heart Journal 22(1): 1-2
1970
ISSN/ISBN: 0019-4832 PMID: 5493997 Document Number: 27929
Document emailed within 1 workday
Related Documents
Masiakowski, J.; Cieszyński, T.; Dyderski, S.; Perz, A. 1984: Biopharmaceutical evaluation of aminophylline suppositories. I. Pharmacological parameters of theophylline from aminophylline suppositories with normal and prolonged time of total deformation Acta Poloniae Pharmaceutica 41(1): 99-104Fedorova, T.A.; Il'ina, I.V.; Sotnikova, T.I.; Rybakova, M.K. 2004: Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease Klinicheskaia Meditsina 82(11): 15-20
Sorokina, E.I.; Davydova, O.B.; Kamenskaia, N.S.; Danilov, V.I. 1979: Carbonate baths in the treatment of ischemic heart disease (postinfarct cardiosclerosis and heart conduction disorder) Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 3: 16-21
Montoya-Cabrera, M.A.; López-Martín, G.; Hernández-Zamora, A. 1984: Treatment of aminophylline poisoning according to its pharmacologic properties Gaceta Medica de Mexico 120(9-10): 347-350
Kuriata, A.V.; Karavanskaia, I.L.; Kushnir, I.S. 2011: The use of metabolic therapy in the treatment of ischemic heart disease in hemodynamically formed insignificant aortic stenosis with chronic heart failure Likars'ka Sprava 2011(7-8): 51-58
Littenberg, B. 1988: Aminophylline treatment in severe, acute asthma. a meta-analysis JAMA 259(11): 1678-1684
Mahajan, S.K.; Mangla, M.; Kishore, K. 2001: Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients Journal of the Association of Physicians of India 49: 1082-1085
Bova, A.A.; Lapitskiĭ, D.V. 2009: Chronic obstructive pulmonary disease and coronary heart disease: approaches to the treatment of combined pathology Klinicheskaia Meditsina 87(2): 8-13
Mokra, D.; Mokry, J.; Tatarkova, Z.; Redfors, B.; Petraskova, M.; Calkovska, A. 2007: Aminophylline treatment in meconium-induced acute lung injury in a rabbit model Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 58 Suppl 5(Part 1): 399-407
Khaĭrutdinov, E.R.; Shugushev, Z.K.; Maksimkin, D.A.; Faĭbushevich, A.G.; Veretnik, G.I.; Arablinskiĭ, A.V.; Tarichko, I.V. 2012: Endovascular treatment of ischemic heart disease in patients with multivessel coronary artery disease: immediate and long-term results Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 7: 8-14
Rasmussen, V.G.; Dupont, E.; Østergaard, K.; Egeblad, H. 2006: Valvular heart disease associated with the treatment of Parkinson disease Ugeskrift for Laeger 168(26-32): 2542-2544
Rozdil'skaia, O.N.; Kaduk, I.G.; Biazrova, V.V. 1993: The use of sodium nitroprusside aerosols combined with ultrasound in the combined treatment of patients with ischemic heart disease and heart failure Likars'ka Sprava 4: 97-100
Collis, N.; Elliot, L.A.; Sharpe, C.; Sharpe, D.T. 1999: Cellulite treatment: a myth or reality: a prospective randomized, controlled trial of two therapies, endermologie and aminophylline cream Plastic and Reconstructive Surgery 104(4): 1110-1114; Discussion: 1115-1117
Sakamoto, T.; Sadanaga, T.; Okazaki, T. 2007: Sequential use of aminophylline and theophylline for the treatment of atropine-resistant bradycardia after spinal cord injury: a case report Journal of Cardiology 49(2): 91-96
Herrmann, G.; Aynesworth, M.B.; Herrmann, G.; Aynesworth, M.B. 1990: Successful treatment of persistent extreme dyspnea "status asthmaticus". use of theophylline ethylene diamine (aminophylline, U. S. P.) intravenously. 1938 Journal of Laboratory and Clinical Medicine 115(4): 512-525
Yarnell, J.W.; Limb, E.S.; Layzell, J.M.; Baker, I.A. 1992: Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies European Heart Journal 13(12): 1602-1605
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Shoĭkhet, I.N.; Klester, E.B.; Golovin, V.A. 2008: Heart rhythm disturbances in patients with chronic obstructive pulmonary disease in aggregate with coronary heart disease Klinicheskaia Meditsina 86(3): 21-26
Behrenbeck, D.W. 1971: The treatment of pulmonary heart disease Zeitschrift für Allgemeinmedizin 47(24): 1227-1232
Metreveli, A.S. 1974: Pulmonary heart disease and its treatment Fel'dsher i Akusherka 39(4): 13-16